Page last updated: 2024-08-22

tranylcypromine and Retinal Degeneration

tranylcypromine has been researched along with Retinal Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayashi, H; Hino, S; Inoue, T; Iwao, K; Kawaji, T; Kirihara, T; Nakao, M; Tanihara, H; Tsutsumi, T	1

Other Studies

1 other study(ies) available for tranylcypromine and Retinal Degeneration

Article	Year
Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity. Investigative ophthalmology & visual science, 2016, 11-01, Volume: 57, Issue:14 Topics: Animals; Apoptosis; Caspase 3; Cell Survival; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Histone Demethylases; Immunoblotting; Immunohistochemistry; Male; Monoamine Oxidase Inhibitors; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Retinal Degeneration; Retinal Ganglion Cells; RNA; Tranylcypromine	2016

Article

Year

Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity.

Investigative ophthalmology & visual science, 2016, 11-01, Volume: 57, Issue:14

Topics: Animals; Apoptosis; Caspase 3; Cell Survival; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Histone Demethylases; Immunoblotting; Immunohistochemistry; Male; Monoamine Oxidase Inhibitors; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Retinal Degeneration; Retinal Ganglion Cells; RNA; Tranylcypromine

2016